Histone deacetylase expression patterns in developing murine optic nerve

BMC Developmental Biology

Teri L Belecky-Adams¹  Deborah C Otteson³  Mahesh Shivanna²  Subramanian Dharmarajan¹  Sarika Tiwari¹ 

[1] Center for Regenerative Biology and Medicine, Indiana University-Purdue University Indianapolis, 723 W Michigan St, Indianapolis IN-46202, India;School of Optometry, MCPHS University, 10 Lincoln Sq., Worcester MA-01608, UK;University of Houston College of Optometry, 4901 Calhoun Rd, Houston, TX 77204-2020, USA

关键词: Glial lamina;    Astrocyte precursors;    Astrocytes;    Optic stalk;    Optic nerve;    Development;    Murine;    Mouse;    HDACs;    Histone deacetylases;   

Others  :  847057
DOI  :  10.1186/1471-213X-14-30

 received in 2014-01-22, accepted in 2014-06-26,  发布年份 2014

【 摘 要 】

Background

Histone deacetylases (HDACs) play important roles in glial cell development and in disease states within multiple regions of the central nervous system. However, little is known about HDAC expression or function within the optic nerve. As a first step in understanding the role of HDACs in optic nerve, this study examines the spatio-temporal expression patterns of methylated histone 3 (K9), acetylated histone 3 (K18), and HDACs 1–6 and 8–11 in the developing murine optic nerve head.

Results

Using RT-qPCR, western blot and immunofluorescence, three stages were analyzed: embryonic day 16 (E16), when astrocyte precursors are found in the optic stalk, postnatal day 5 (P5), when immature astrocytes and oligodendrocytes are found throughout the optic nerve, and P30, when optic nerve astrocytes and oligodendrocytes are mature. Acetylated and methylated histone H3 immunoreactivity was co-localized in the nuclei of most SOX2 positive glia within the optic nerve head and adjacent optic nerve at all developmental stages. HDACs 1–11 were expressed in the optic nerve glial cells at all three stages of optic nerve development in the mouse, but showed temporal differences in overall levels and subcellular localization. HDACs 1 and 2 were predominantly nuclear throughout optic nerve development and glial cell maturation. HDACs 3, 5, 6, 8, and 11 were predominantly cytoplasmic, but showed nuclear localization in at least one stage of optic nerve development. HDACs 4, 9 and10 were predominantly cytoplasmic, with little to no nuclear expression at any time during the developmental stages examined.

Conclusions

Our results showing that HDACs 1, 2, 3, 5, 6, 8, and 11 were each localized to the nuclei of SOX2 positive glia at some stages of optic nerve development and maturation and extend previous reports of HDAC expression in the aging optic nerve. These HDACs are candidates for further research to understand how chromatin remodeling through acetylation, deacetylation and methylation contributes to glial development as well as their injury response.

【 授权许可】

   
2014 Tiwari et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 2.

Figure 6.

Figure 7.

Figure 8.

【 参考文献 】

• [1]Sofroniew MV, Vinters HV: Astrocytes: biology and pathology. Acta Neuropathol 2010, 119(1):7-35.
• [2]Butt AM, Pugh M, Hubbard P, James G: Functions of optic nerve glia: axoglial signalling in physiology and pathology. Eye 2004, 18(11):1110-1121.
• [3]Panickar KS, Norenberg MD: Astrocytes in cerebral ischemic injury: morphological and general considerations. Glia 2005, 50(4):287-298.
• [4]Liu Y, Rao MS: Glial progenitors in the CNS and possible lineage relationships among them. Biol Cell 2004, 96(4):279-290.
• [5]Chu Y, Hughes S, Chan-Ling T: Differentiation and migration of astrocyte precursor cells and astrocytes in human fetal retina: relevance to optic nerve coloboma. FASEB J 2001, 15(11):2013-2015.
• [6]Fruttiger M: Development of the retinal vasculature. Angiogenesis 2007, 10(2):77-88.
• [7]Dakubo GD, Wang YP, Mazerolle C, Campsall K, McMahon AP, Wallace VA: Retinal ganglion cell-derived sonic hedgehog signaling is required for optic disc and stalk neuroepithelial cell development. Development 2003, 130(13):2967-2980.
• [8]Balaratnasingam C, Kang MH, Yu P, Chan G, Morgan WH, Cringle SJ, Yu DY: Comparative quantitative study of astrocytes and capillary distribution in optic nerve laminar regions. Exp Eye Res 2014, 121:11-22.
• [9]Miller RH: Regulation of oligodendrocyte development in the vertebrate CNS. Prog Neurobiol 2002, 67(6):451-467.
• [10]Mi H, Haeberle H, Barres BA: Induction of astrocyte differentiation by endothelial cells. J Neurosci 2001, 21(5):1538-1547.
• [11]Morcillo J, Martinez-Morales JR, Trousse F, Fermin Y, Sowden JC, Bovolenta P: Proper patterning of the optic fissure requires the sequential activity of BMP7 and SHH. Development 2006, 133(16):3179-3190.
• [12]Sehgal R, Sheibani N, Rhodes SJ, Belecky Adams TL: BMP7 and SHH regulate Pax2 in mouse retinal astrocytes by relieving TLX repression. Dev Biol 2009, 332(2):429-443.
• [13]Sanosaka T, Namihira M, Nakashima K: Epigenetic mechanisms in sequential differentiation of neural stem cells. Epigenetics 2009, 4(2):89-92.
• [14]Hsieh J, Gage FH: Epigenetic control of neural stem cell fate. Curr Opin Genet Dev 2004, 14(5):461-469.
• [15]Schubeler D, MacAlpine DM, Scalzo D, Wirbelauer C, Kooperberg C, van Leeuwen F, Gottschling DE, O’Neill LP, Turner BM, Delrow J, Bell SP, Groudine M: The histone modification pattern of active genes revealed through genome-wide chromatin analysis of a higher eukaryote. Genes Dev 2004, 18(11):1263-1271.
• [16]Knipe DM, Cliffe A: Chromatin control of herpes simplex virus lytic and latent infection. Nat Rev Microbiol 2008, 6(3):211-221.
• [17]Haberland M, Montgomery RL, Olson EN: The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet 2009, 10(1):32-42.
• [18]Imhof A: Epigenetic regulators and histone modification. Brief Funct Genomic Proteomic 2006, 5(3):222-227.
• [19]Nusinzon I, Horvath CM: Histone deacetylases as transcriptional activators? Role reversal in inducible gene regulation. Sci STKE 2005, 2005(296):re11.
• [20]Peng L, Seto E: Deacetylation of nonhistone proteins by HDACs and the implications in cancer. Handb Exp Pharmacol 2011, 206:39-56.
• [21]Glozak MA, Sengupta N, Zhang X, Seto E: Acetylation and deacetylation of non-histone proteins. Gene 2005, 363:15-23.
• [22]Rosato RR, Wang Z, Gopalkrishnan RV, Fisher PB, Grant S: Evidence of a functional role for the cyclin-dependent kinase-inhibitor p21WAF1/CIP1/MDA6 in promoting differentiation and preventing mitochondrial dysfunction and apoptosis induced by sodium butyrate in human myelomonocytic leukemia cells (U937). Int J Oncol 2001, 19(1):181-191.
• [23]Marks PA, Dokmanovic M: Histone deacetylase inhibitors: discovery and development as anticancer agents. Expert Opin Investig Drugs 2005, 14(12):1497-1511.
• [24]Turner BM: Cellular memory and the histone code. Cell 2002, 111(3):285-291.
• [25]Wang Z, Zang C, Cui K, Schones DE, Barski A, Peng W, Zhao K: Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. Cell 2009, 138(5):1019-1031.
• [26]Petros TJ, Williams SE, Mason CA: Temporal regulation of EphA4 in astroglia during murine retinal and optic nerve development. Mol Cell Neurosci 2006, 32(1–2):49-66.
• [27]Pernet V, Joly S, Christ F, Dimou L, Schwab ME: Nogo-A and myelin-associated glycoprotein differently regulate oligodendrocyte maturation and myelin formation. J Neurosci 2008, 28(29):7435-7444.
• [28]Dakubo GD, Beug ST, Mazerolle CJ, Thurig S, Wang Y, Wallace VA: Control of glial precursor cell development in the mouse optic nerve by sonic hedgehog from retinal ganglion cells. Brain Res 2008, 1228:27-42.
• [29]Sun D, Lye-Barthel M, Masland RH, Jakobs TC: The morphology and spatial arrangement of astrocytes in the optic nerve head of the mouse. J Comp Neurol 2009, 516(1):1-19.
• [30]Hsieh J, Nakashima K, Kuwabara T, Mejia E, Gage FH: Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proc Natl Acad Sci U S A 2004, 101(47):16659-16664.
• [31]Cunliffe VT, Casaccia-Bonnefil P: Histone deacetylase 1 is essential for oligodendrocyte specification in the zebrafish CNS. Mech Dev 2006, 123(1):24-30.
• [32]Stanke J, Moose HE, El-Hodiri HM, Fischer AJ: Comparative study of Pax2 expression in glial cells in the retina and optic nerve of birds and mammals. J Comp Neurol 2010, 518(12):2316-2333.
• [33]Gotoh H, Ono K, Takebayashi H, Harada H, Nakamura H, Ikenaka K: Genetically-defined lineage tracing of Nkx2.2-expressing cells in chick spinal cord. Dev Biol 2011, 349(2):504-511.
• [34]Qi Y, Cai J, Wu Y, Wu R, Lee J, Fu H, Rao M, Sussel L, Rubenstein J, Qiu M: Control of oligodendrocyte differentiation by the Nkx2.2 homeodomain transcription factor. Development 2001, 128(14):2723-2733.
• [35]Small RK, Riddle P, Noble M: Evidence for migration of oligodendrocyte–type-2 astrocyte progenitor cells into the developing rat optic nerve. Nature 1987, 328(6126):155-157.
• [36]Baltan S: Histone deacetylase inhibitors preserve function in aging axons. J Neurochem 2012, 123(Suppl 2):108-115.
• [37]Escaffit F, Vaute O, Chevillard-Briet M, Segui B, Takami Y, Nakayama T, Trouche D: Cleavage and cytoplasmic relocalization of histone deacetylase 3 are important for apoptosis progression. Mol Cellular Biol 2007, 27(2):554-567.
• [38]Paroni G, Mizzau M, Henderson C, Del Sal G, Schneider C, Brancolini C: Caspase-dependent regulation of histone deacetylase 4 nuclear-cytoplasmic shuttling promotes apoptosis. Mol Biol Cell 2004, 15(6):2804-2818.
• [39]Schlumm F, Mauceri D, Freitag HE, Bading H: Nuclear calcium signaling regulates nuclear export of a subset of class IIa histone deacetylases following synaptic activity. J Biol Chem 2013, 288(12):8074-8084.
• [40]Kao HY, Verdel A, Tsai CC, Simon C, Juguilon H, Khochbin S: Mechanism for nucleocytoplasmic shuttling of histone deacetylase 7. J Biol Chem 2001, 276(50):47496-47507.
• [41]McKinsey TA, Zhang CL, Olson EN: Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5. Proc Natl Acad Sci U S A 2000, 97(26):14400-14405.
• [42]McKinsey TA, Zhang CL, Lu J, Olson EN: Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 2000, 408(6808):106-111.
• [43]Paroni G, Cernotta N, Dello Russo C, Gallinari P, Pallaoro M, Foti C, Talamo F, Orsatti L, Steinkuhler C, Brancolini C: PP2A regulates HDAC4 nuclear import. Mol Biol Cell 2008, 19(2):655-667.
• [44]Greco TM, Yu F, Guise AJ, Cristea IM: Nuclear import of histone deacetylase 5 by requisite nuclear localization signal phosphorylation. Mol Cell Proteomics 2011, 10(2):M110 004317.
• [45]Karolczak-Bayatti M, Sweeney M, Cheng J, Edey L, Robson SC, Ulrich SM, Treumann A, Taggart MJ, Europe-Finner GN: Acetylation of heat shock protein 20 (Hsp20) regulates human myometrial activity. J Biol Chem 2011, 286(39):34346-34355.
• [46]Marks PA, Xu WS: Histone deacetylase inhibitors: Potential in cancer therapy. J Cell Biochem 2009, 107(4):600-608.
• [47]Greenbaum D, Colangelo C, Williams K, Gerstein M: Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol 2003, 4(9):117.
• [48]Roccaro AM, Sacco A, Jia X, Azab AK, Maiso P, Ngo HT, Azab F, Runnels J, Quang P, Ghobrial IM: microRNA-dependent modulation of histone acetylation in Waldenstrom macroglobulinemia. Blood 2010, 116(9):1506-1514.
• [49]Liu F, Dowling M, Yang XJ, Kao GD: Caspase-mediated specific cleavage of human histone deacetylase 4. J Biol Chem 2004, 279(33):34537-34546.
• [50]Boyault C, Sadoul K, Pabion M, Khochbin S: HDAC6, at the crossroads between cytoskeleton and cell signaling by acetylation and ubiquitination. Oncogene 2007, 26(37):5468-5476.
• [51]Brandl A, Heinzel T, Kramer OH: Histone deacetylases: salesmen and customers in the post-translational modification market. Biol Cell 2009, 101(4):193-205.
• [52]Gopal YN, Van Dyke MW: Depletion of histone deacetylase protein: a common consequence of inflammatory cytokine signaling? Cell Cycle 2006, 5(23):2738-2743.
• [53]Zhao HL, Ueki N, Hayman MJ: The Ski protein negatively regulates Siah2-mediated HDAC3 degradation. Biochem Biophys Res Commun 2010, 399(4):623-628.
• [54]Liu H, Hu Q, Kaufman A, D’Ercole AJ, Ye P: Developmental expression of histone deacetylase 11 in the murine brain. J Neurosci Res 2008, 86(3):537-543.
• [55]Schwechter BR, Millet LE, Levin LA: Histone deacetylase inhibition-mediated differentiation of RGC-5 cells and interaction with survival. Invest Ophthalmol Vis Sci 2007, 48(6):2845-2857.
• [56]Shen S, Li J, Casaccia-Bonnefil P: Histone modifications affect timing of oligodendrocyte progenitor differentiation in the developing rat brain. J Cell Biol 2005, 169(4):577-589.
• [57]Swiss VA, Nguyen T, Dugas J, Ibrahim A, Barres B, Androulakis IP, Casaccia P: Identification of a gene regulatory network necessary for the initiation of oligodendrocyte differentiation. PLoS One 2011, 6(4):e18088.
• [58]Liu Z, Hu X, Cai J, Liu B, Peng X, Wegner M, Qiu M: Induction of oligodendrocyte differentiation by Olig2 and Sox10: evidence for reciprocal interactions and dosage-dependent mechanisms. Dev Biol 2007, 302(2):683-693.
• [59]Liu H, Hu Q, D’Ercole AJ, Ye P: Histone deacetylase 11 regulates oligodendrocyte-specific gene expression and cell development in OL-1 oligodendroglia cells. Glia 2009, 57(1):1-12.
• [60]Conway GD, O’Bara MA, Vedia BH, Pol SU, Sim FJ: Histone deacetylase activity is required for human oligodendrocyte progenitor differentiation. Glia 2012, 60(12):1944-1953.
• [61]Marin-Husstege M, Muggironi M, Liu A, Casaccia-Bonnefil P: Histone deacetylase activity is necessary for oligodendrocyte lineage progression. J Neurosci 2002, 22(23):10333-10345.
• [62]Dewald LE, Rodriguez JP, Levine JM: The RE1 binding protein REST regulates oligodendrocyte differentiation. J Neurosci 2011, 31(9):3470-3483.
• [63]Butler R, Bates GP: Histone deacetylase inhibitors as therapeutics for polyglutamine disorders. Nat Rev Neurosci 2006, 7(10):784-796.
• [64]Delcuve GP, Khan DH, Davie JR: Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors. Clin Epigenetics 2012, 4(1):5.
• [65]MacDonald JL, Roskams AJ: Histone deacetylases 1 and 2 are expressed at distinct stages of neuro-glial development. Dev Dyn 2008, 237(8):2256-2267.
• [66]Siebzehnrubl FA, Buslei R, Eyupoglu IY, Seufert S, Hahnen E, Blumcke I: Histone deacetylase inhibitors increase neuronal differentiation in adult forebrain precursor cells. Exp Brain Res 2007, 176(4):672-678.
• [67]Ye F, Chen Y, Hoang T, Montgomery RL, Zhao XH, Bu H, Hu T, Taketo MM, van Es JH, Clevers H, Hsieh J, Bassel-Duby R, Olson EN, Lu QR: HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the beta-catenin-TCF interaction. Nat Neurosci 2009, 12(7):829-838.
• [68]Shaked M, Weissmuller K, Svoboda H, Hortschansky P, Nishino N, Wolfl S, Tucker KL: Histone deacetylases control neurogenesis in embryonic brain by inhibition of BMP2/4 signaling. PLoS One 2008, 3(7):e2668.
• [69]Asano H, Aonuma M, Sanosaka T, Kohyama J, Namihira M, Nakashima K: Astrocyte differentiation of neural precursor cells is enhanced by retinoic acid through a change in epigenetic modification. Stem Cells 2009, 27(11):2744-2752.
• [70]Scholl C, Weissmuller K, Holenya P, Shaked-Rabi M, Tucker KL, Wolfl S: Distinct and overlapping gene regulatory networks in BMP- and HDAC-controlled cell fate determination in the embryonic forebrain. BMC Genomics 2012, 13(1):298.
• [71]Rajan P, Panchision DM, Newell LF, McKay RD: BMPs signal alternately through a SMAD or FRAP-STAT pathway to regulate fate choice in CNS stem cells. J Cell Biol 2003, 161(5):911-921.
• [72]Zhang Z, Qin X, Tong N, Zhao X, Gong Y, Shi Y, Wu X: Valproic acid-mediated neuroprotection in retinal ischemia injury via histone deacetylase inhibition and transcriptional activation. Exp Eye Res 2012, 94(1):98-108.
• [73]Biermann J, Grieshaber P, Goebel U, Martin G, Thanos S, Di Giovanni S, Lagreze WA: Valproic acid-mediated neuroprotection and regeneration in injured retinal ganglion cells. Invest Ophthalmol Vis Sci 2010, 51(1):526-534.
• [74]Pelzel HR, Schlamp CL, Waclawski M, Shaw MK, Nickells RW: Silencing of Fem1cR3 gene expression in the DBA/2J mouse precedes retinal ganglion cell death and is associated with histone deacetylase activity. Invest Ophthalmol Vis Sci 2012, 53(3):1428-1435.
• [75]Mouse Genome Sequencing C, Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, Agarwal P, Agarwala R, Ainscough R, Alexandersson M, An P, Antonarakis SE, Attwood J, Baertsch R, Bailey J, Barlow K, Beck S, Berry E, Birren B, Bloom T, Bork P, Botcherby M, Bray N, Brent MR, Brown DG, Brown SD, Bult C, Burton J, Butler J, Campbell RD, Carninci P, et al.: Initial sequencing and comparative analysis of the mouse genome. Nature 2002, 420(6915):520-562.
• [76]Rocha-Martins M, Njaine B, Silveira MS: Avoiding pitfalls of internal controls: validation of reference genes for analysis by qRT-PCR and Western blot throughout rat retinal development. PLoS One 2012, 7(8):e43028.
• [77]Hruz T, Wyss M, Docquier M, Pfaffl MW, Masanetz S, Borghi L, Verbrugghe P, Kalaydjieva L, Bleuler S, Laule O, Descombes P, Gruissem W, Zimmermann P: RefGenes: identification of reliable and condition specific reference genes for RT-qPCR data normalization. BMC Genomics 2011, 12:156.
• [78]Pfaffl MW, Horgan GW, Dempfle L: Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002, 30(9):e36.